Breast-Specific Gamma Imaging (BSGI), Molecular Breast Imaging (MBI), or scintimammography with breast-specific gamma camera

BlueCross BlueShield Association
Record ID 32013000681
English
Authors' objectives: To ascertain the accuracy (sensitivity, specificity, positive predictive value, and negative predictive value) of breast-specific gamma imaging, molecular breast imaging, or scintimammography using a breast-specific gamma camera (referred to as BSGI/MBI hereafter) compared to alternative imaging modalities such as MRI, ultrasound (US), and mammography, when used in women undergoing breast cancer screening, including those with dense breasts or at high risk of breast cancer, or in women with suspicious physical or imaging findings.
Details
Project Status: Completed
URL for project: http://www.bcbs.com/blueresources/tec/vols/28/breast-specific-gamma-imaging.html
Year Published: 2013
URL for published report: http://www.bcbs.com/blueresources/tec/vols/28/28_02.pdf
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Blue Cross Blue Shield Insurance Plans
  • Drug Approval
  • Female
  • Radiation Dosage
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Technetium Tc 99m Sestamibi
  • Technology Assessment, Biomedical
  • United States
  • United States Food and Drug Administration
  • Breast Neoplasms
  • Mammography
  • Molecular Imaging
  • Radionuclide Imaging
Contact
Organisation Name: BlueCross BlueShield Association
Contact Address: BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name: tec@bcbsa.com
Contact Email: tec@bcbsa.com
Copyright: BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.